Arphra
live
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%

SYK

Stryker Corporation
HealthcareMedical - DevicesUSUSDPeers →
$305.64
LiveJun 11, 2026
AI Brief
Market cap
$117.17B
52w range
281.00 – 404.87
P / E
EPS · FY 2025
$8.40
Volume
2.03M
Revenue · FY 2025
$25.12B
+11.16% YoY

Explain this page

Arphra AI
Business description
· company · SEC profile

Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Founded
IPO
Mar 17, 1980
Employees
53,000
HQ
Portage, MI
CEO
Kevin A. Lobo
CFO
Preston Wells
Exchange
NYSE
Fiscal year
Identifiers
· company_identifiers
CIK0000310764
CUSIP863667101
ISINUS8636671013
FIGISYK US
LEI
Cross-listings
· companies · ISIN
  • SYKPrimaryNew York Stock ExchangeusUSD$118.4B
  • SYK.DEDeutsche Börse XETRAusEUR$119.15B
  • 0R2S.LLondon Stock ExchangeusUSD$1.16B
The global universe keeps only the primary listing; the other venues for this security are shown here.